Target Group, Inc. (Canada) (CBDY)
0.0007
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Target Group Net Income (Quarterly) : -0.2398M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2398M |
| March 31, 2026 | -0.5504M |
| December 31, 2025 | -0.5523M |
| September 30, 2025 | -0.4794M |
| June 30, 2025 | -0.2198M |
| March 31, 2025 | -0.1082M |
| December 31, 2024 | 0.216M |
| September 30, 2024 | -0.529M |
| June 30, 2024 | 0.6667M |
| March 31, 2024 | -0.1932M |
| December 31, 2023 | -0.185M |
| September 30, 2023 | -0.3568M |
| June 30, 2023 | 0.9638M |
| March 31, 2023 | -0.7457M |
| December 31, 2022 | -3.922M |
| September 30, 2022 | -0.2861M |
| June 30, 2022 | 0.2476M |
| March 31, 2022 | -0.5597M |
| December 31, 2021 | -0.0606M |
| September 30, 2021 | 2.197M |
| June 30, 2021 | 0.827M |
| March 31, 2021 | -2.690M |
| December 31, 2020 | -5.361M |
| September 30, 2020 | -3.917M |
| June 30, 2020 | -0.6014M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.805M |
| December 31, 2019 | -6.062M |
| September 30, 2019 | -0.9847M |
| June 30, 2019 | -2.181M |
| March 31, 2019 | -1.140M |
| December 31, 2018 | 0.5546M |
| September 30, 2018 | -1.831M |
| June 30, 2018 | -0.8445M |
| March 31, 2018 | 0.2207M |
| December 31, 2017 | -0.6865M |
| September 30, 2017 | -0.4496M |
| June 30, 2017 | -0.057M |
| March 31, 2017 | -0.5496M |
| December 31, 2016 | -0.0942M |
| September 30, 2016 | -1.536M |
| June 30, 2016 | -0.2868M |
| March 31, 2016 | -0.428M |
| December 31, 2015 | -2.316M |
| September 30, 2015 | -0.2075M |
| June 30, 2015 | -0.1144M |
| March 31, 2015 | -0.1098M |
| December 31, 2014 | -0.2402M |
| September 30, 2014 | -0.1174M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -0.0008M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Lexaria Bioscience Corp. | -1.993M |
| InMed Pharmaceuticals, Inc. | -4.843M |
| XORTX Therapeutics, Inc. | -1.691M |
| NervGen Pharma Corp. | -21.10M |
| Milestone Pharmaceuticals, Inc. | -28.61M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.371M |
| Total Expenses (Quarterly) | 1.611M |
| EPS Diluted (Quarterly) | -0.0004 |
| Enterprise Value | 11.59M |
| Gross Profit Margin (Quarterly) | 28.44% |
| Profit Margin (Quarterly) | -17.49% |
| Earnings Yield | -428.6% |
| Normalized Earnings Yield | -414.29 |